EphA2 Positive Malignant Glioma
1 clinical trials · Condition
◉ Watch EphA2 Positive Malignant Glioma
| Record | Firm | Date |
|---|---|---|
| CAR-T Cell Immunotherapy for EphA2 Positive Malignant Glioma Patients (NCT02575261) | Fuda Cancer Hospital, Guangzhou | 2015-09-01 |
Track EphA2 Positive Malignant Glioma automatically
Every clearance here is in the API, with alerts when new ones post.